Director Peter W. Getsinger filed a Form 4 with the SEC on September 23, 2026, reporting the exercise of a portion of a stock option in Argan Inc (NYSE:AGX) on September 22, 2026.

Key Highlights

  • Option exercise: Getsinger exercised a portion of a stock option originally awarded on December 23, 2019, purchasing 1,000 shares at $40.15 per share using the net settle method.
  • Shares acquired: 895 shares of common stock were acquired (transaction code M) on September 22, 2026, at a price of $40.15.
  • Direct ownership following transaction: Getsinger directly holds 5,775 shares of common stock following the reported transaction.
  • Indirect holdings: An additional 133 shares are held indirectly in a custody account for a child, and 267 shares are held indirectly in a children's trust.
  • Remaining derivative securities: 2,000 options to purchase common stock at $40.15 remain directly held, with an expiration date of December 23, 2029.

Getsinger Option Exercise Details and Resulting Ownership in Argan Inc

According to the filing, Peter W. Getsinger, a director of Argan Inc (NYSE:AGX), exercised a portion of a stock option on September 22, 2026. The filing states that the option was originally awarded on December 23, 2019, and that Getsinger used the net settle method to purchase 1,000 shares at an exercise price of $40.15 per share. Under the net settle method, 895 shares were recorded as acquired in Table I of the filing.

Following the reported transaction, the filing discloses that Getsinger directly holds 5,775 shares of Argan common stock. In addition, the filing reports two indirect holdings: 133 shares held in a custody account for a child, and 267 shares held in a children's trust. These indirect positions were not part of the reported transaction and are listed separately in the filing.

With respect to derivative securities, the filing shows that Getsinger exercised 1,000 options (transaction code M) out of a prior position. Following the exercise, 2,000 options to purchase common stock at $40.15 per share remain directly held, with an exercisable date of December 23, 2020, and an expiration date of December 23, 2029, according to the filing.

What Was Disclosed

The filing reports a single option exercise transaction by Argan Inc director Peter W. Getsinger on September 22, 2026, involving 1,000 shares at $40.15 using the net settle method, resulting in a net acquisition of 895 shares and a direct holdings total of 5,775 shares.